The drug, suzetrigine, will be sold under the brand name Journavx and is the first new class of pain medicine approved in ...
FDA approves new type of non-opioid pain medication in two decades - The new drug will be many times more expensive than a ...
The FDA has approved Journavx, a new non-opioid pain medication designed to reduce addiction and overdose risks.
The drug, Journavx by Vertex Pharmaceuticals, blocks pain signals to the brain, making it nonaddictive. The Food and Drug ...
The new drug will carry a list price of $15.50 per pill, making it many times more expensive than comparable opioids, which are often available as generics for $1 or less. Vertex began researching ...
The new drug will carry a list price of $15.50 per pill, making it many times more expensive than comparable opioids, which are often available as generics for $1 or less. Advertising Vertex began ...
The Vertex drug is a milestone after a long history of unsuccessful efforts to develop painkillers without the addictive ...